Who invested in Magnus Medical

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 5 months ago

Follow Magnus Medical and see its new rounds in your feed. Start following

Funding summaryUpdated 5 Nov 2026

$49Mraised across 1 round since 2026, from 1 source

Latest round: Round, $49MMay 2026
Investors: 0

See who backed them

The rounds

May 2026
Round$49M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $49M sold, first sale May 2026

Funding filed with regulators

Magnus Medical filed 3 raises, $113M in all. Filings say how much was sold and to how many investors; they never name the investors.

May 2026$49M10 investorsof $77M offeredSEC Form D
May 2025$24M6 investorsof $77M offeredSEC Form D
Feb 2025$40M10 investorsof $59M offeredSEC Form D

Founders and team

From Magnus Medical's own website: 7 on the team.

Achal Singh AchrolChief Executive Officer
David DangVice President of Finance
Dee KolanekVice President of Market Access & Reimbursement
Huyen DuongVice President of Clinical, Quality and Regulatory
Matt WallaceVice President of Sales
Romain Moreau-GobardSenior Vice President of Technology
Trevor KeatingVice President of Marketing

Also claim to have backed them

This firm lists Magnus Medical as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.